Catalent, Inc. to Present at the 36th Annual J.P. Morgan Health Care Conference
15 December 2017 - 8:15AM
Business Wire
Catalent, Inc. (NYSE:CTLT), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, today announced that John
Chiminski, Chairman & Chief Executive Officer, will present at
the 36th Annual J.P. Morgan Health Care Conference at 11:00 a.m. PT
on Monday, January 8, 2018 in San Francisco, CA.
A live webcast of the presentation will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs over
10,000 people, including over 1,400 scientists, at more than 30
facilities across 5 continents and in fiscal 2017 generated more
than $2 billion in annual revenue. Catalent is headquartered in
Somerset, N.J. For more information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171214005982/en/
Investors:Catalent, Inc.Thomas Castellano,
732-537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2024 to May 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From May 2023 to May 2024